NAMPT and familial pancreatic carcinoma: Abrogating the regeneration of NAD by inhibiting nicotinamide phosphoribosyltransferase disrupts aerobic glycolysis and leads to pancreatic cancer cell growth inhibition in vitro and in vivo, although no tumor regressions were seen in in vivo models.